Nephrotic Syndrome Diagnostics & Therapeutics Market Demand Analysis, Growth, Trends and Forecast - 2031
The global nephrotic syndrome diagnostics & therapeutics market is
anticipated to grow at a CAGR of around 5.6% during the forecast period (2024-2031).
The key factor to drive the market growth includesthe increasing prevalence of
diabetes that results in increased chances of nephrotic syndrome. For instance,
In the European Union, approximately 32.3 million adults were diagnosed with
diabetes in 2019, up from an estimated 16.8 million adults in 2000. In 2019, it
was estimated that around 24.2 million people in Europe will be having diabetes
but will go undiagnosed.Since 2000, the number of men diagnosed with diabetes
has more than doubled, rising from about 7.3 million in 2000 to 16.7 million in
2019. Women with diabetes have also increased significantly, from 9.5 million
in 2000 to 15.6 million in 2019.
Get Free Sample link @ https://www.omrglobal.com/request-sample/nephrotic-syndrome-diagnostics-therapeutics-market
Rising
acquisitions, product approval, collaborations among the major players in the
market also propel the growth of the market. For instance, in April 2019,
Angion announced a partnership agreement with Nephrotic Syndrome Study Network
(NEPTUNE)in order to investigate ANG-3070. This clinical research is based on
understanding and treatment of kidney disorders.These findings of the research
will supportdetermining the inclusion requirements for a biomarker stratified
prospective clinical trial evaluating the safety and efficacy of ANG-3070 in
primary Focal segmental glomerulosclerosis (FSGS) patients, ensuring that the
most likely patients benefit from treatment.
Full report of Nephrotic Syndrome Diagnostics &
Therapeutics Market available @ https://www.omrglobal.com/industry-reports/nephrotic-syndrome-diagnostics-therapeutics-market
Market
Coverage
- Segment Covered-
o By Diagnosis Test
o By Treatment
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape-
Key
questions addressed by the report
- What is the market growth rate?
- Which segment and region
dominate the market in the base year?
- Which segment and region will
project the fastest growth in the market?
- How COVID-19 impacted the
market?
o Deviation from the pre-COVID-19
forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing
challenges to sustain growth?
- Where is the investment
opportunity?
Global
Nephrotic Syndrome Diagnostics & Therapeutics Market Report Segment
By
Diagnosis Tests
- Urinalysis
- Blood Tests
- Kidney Biopsy
- Others (CT Scan, Renal
Ultra-Sonography)
By
Treatment
- Blood Pressure Lowering
Medications
o Angiotensin-Converting Enzyme (ACE)
Inhibitors
o Angiotensin Receptor Blockers (ARBs)
o Others (Renin Inhibitors and
Benazepril)
- Immune System-Suppressing
Medications
- Cholesterol-Reducing Medications
- Others (Blood Thinners)
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90
sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/nephrotic-syndrome-diagnostics-therapeutics-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known
for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services. The company also offers Digital Marketing services through its
subsidiary OMR Digital and Software development and Consulting Services through
another subsidiary Encanto Technologies.
Comments
Post a Comment